Filtros de búsqueda

Lista de obras de

1291Sexually Transmitted Diseases Clinic Based Hepatitis C Testing and Linkage to Care.

artículo científico publicado en 2014

2549. Variance Between Clinicians and Guidelines in Management of HIV/HCV Coinfection

A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy

artículo científico publicado en 2006

A Randomized Controlled Trial of Cash Incentives or Peer Support to Increase HCV Treatment for Persons With HIV Who Use Drugs: The CHAMPS Study

article

A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users

artículo científico publicado en 2005

A promising new anti-HCV protease inhibitor

artículo científico publicado en 2003

A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection

artículo científico publicado en 2013

A22 Phylogenetic clustering of hepatitis C virus infection among people who inject drugs in Baltimore

About This Continuing Medical Education Activity

artículo científico publicado en 2016

Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIV

artículo científico publicado en 2019

Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin

artículo científico publicado en 2013

Advanced liver fibrosis and care continuum in emergency department patients with chronic hepatitis C

artículo científico publicado en 2018

Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 1.

artículo científico publicado en 2010

All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-naïve patients with genotype 1 HCV infection

artículo científico publicado en 2014

All-oral direct-acting antiviral therapy in HCV-advanced liver disease is effective in real-world practice: observations through HCV-TARGET database

artículo científico publicado en 2016

An Education and Field Experience Program to Increase Detection of Human Immunodeficiency Virus and Hepatitis C Virus.

artículo científico publicado en 2018

Analysis of site performance in academic-based and community-based centers in the IDEAL Study

artículo científico publicado en 2013

Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial

artículo científico publicado en 2013

Anemia in the Treatment of Hepatitis C Virus Infection ⬇️

artículo científico publicado el 1 de enero de 2003

Antimicrobial Access in the 21st Century: Delays and Critical Shortages.

artículo científico publicado en 2016

Antiretroviral Effects on Host Lipoproteins Are Associated With Changes in Hepatitis C Virus (HCV) RNA Levels in Human Immunodeficiency Virus/HCV Coinfected Individuals.

artículo científico publicado en 2015

Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events

artículo científico publicado en 2008

Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients

artículo científico publicado en 2014

Antiretroviral-associated liver injury

artículo científico publicado en 2003

Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection.

artículo científico publicado en 2009

Association of CYP2B6 Single-Nucleotide Polymorphisms Altering Efavirenz Metabolism With Hepatitis C Virus (HCV) Treatment Relapse Among Human Immunodeficiency Virus/HCV-Coinfected African Americans Receiving Ledipasvir/Sofosbuvir in the ION-4 Trial

artículo científico publicado en 2018

Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C

artículo científico publicado en 2011

Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients

artículo científico publicado en 2012

Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore.

artículo científico publicado en 2019

Barriers to Hepatitis C Virus (HCV) Treatment Initiation in Patients With Human Immunodeficiency Virus/HCV Coinfection: Lessons From the Interferon Era.

artículo científico publicado en 2017

Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infection

artículo científico publicado en 2007

Boceprevir for untreated chronic HCV genotype 1 infection

artículo científico publicado en 2011

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial.

artículo científico publicado en 2013

Building a Community - Academic Partnership to Enhance Hepatitis C Virus Screening

artículo científico publicado en 2016

Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India

artículo científico publicado en 2016

Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study

artículo científico publicado en 2014

Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.

artículo científico publicado en 2008

Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel

artículo científico publicado en 2007

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

artículo científico publicado en 2002

Care of patients with hepatitis C and HIV co-infection

artículo científico publicado en 2004

Care2Cure: A randomized controlled trial protocol for evaluating nurse case management to improve the hepatitis C care continuum within HIV primary care

article

Center-level trends in utilization of HCV-exposed donors for HCV-uninfected kidney and liver transplant recipients in the United States

artículo científico publicado en 2019

Cervical injection drug use: a pain in the neck

artículo científico publicado el 1 de agosto de 2010

Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients

artículo científico publicado en 2011

Challenges in treatment of hepatitis C among patients with hepatocellular carcinoma.

artículo científico publicado en 2017

Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy

Changes in Utilization and Discard of Hepatitis C-Infected Donor Livers in the Recent Era.

artículo científico publicado en 2016

Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection.

artículo científico publicado en 2004

Changes in practice and perception of hepatitis C and liver transplantation: Results of a national survey

scientific article published on 21 September 2018

Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: safety, antiviral activity, resistance, and pharmacokinetics

artículo científico publicado en 2013

Cigarette Smoking Behaviors and Beliefs in Persons Living With Hepatitis C.

artículo científico publicado en 2016

Cigarette Smoking in Persons Living with Hepatitis C: the National Health and Nutrition Examination Survey (NHANES), 1999-2014.

artículo científico publicado en 2018

Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial

artículo científico publicado en 2013

Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus

artículo científico publicado en 2014

Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection ⬇️

artículo científico publicado el 19 de febrero de 2011

Correlation Between Tenofovir Drug Levels and the Renal Biomarkers RBP-4 and ß2M in the ION-4 Study Cohort

scientific article published on 24 January 2019

Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individuals

artículo científico publicado en 2014

Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection

artículo científico publicado en 2014

Cost-effectiveness of peginterferon alfa-2a (40kDa) plus ribavirin in patients with HIV and hepatitis C virus co-infection

artículo científico publicado en 2006

Current and Evolving Treatments of Genotype 1 Hepatitis C Virus

artículo científico publicado en 2015

Current management of hepatitis C virus infection in patients with HIV co-infection

artículo científico publicado en 2013

Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.

artículo científico publicado en 2015

Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study

artículo científico publicado en 2014

Daclatasvir plus sofosbuvir for HCV infection

artículo científico publicado en 2014

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

artículo científico publicado en 2014

Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial

artículo científico publicado en 2004

Defining the standard of care: randomized controlled trials for the treatment of hepatitis C in the HIV-infected person

artículo científico publicado en 2004

Detection of liver disease in injection drug users

artículo científico publicado en 2008

Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine

artículo científico publicado en 2020

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

artículo científico publicado en 2006

Development of sofosbuvir for the treatment of hepatitis C virus infection

artículo científico

Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.

artículo científico publicado en 2018

Directly observed therapy of sofosbuvir/ribavirin +/- peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT).

artículo científico publicado en 2017

Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors

artículo científico publicado en 2004

Déjà vu all over again: retreatment of HCV DAA failures- same satisfactory results, same unanswered questions

artículo científico publicado en 2020

Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: results of a randomized clinical study

artículo científico publicado en 2005

Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study

artículo científico publicado en 2016

Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response

artículo científico publicado en 2016

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

artículo científico publicado en 2015

Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial

artículo científico publicado en 2013

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Co-infected with Hepatitis C Virus and Human Immunodeficiency Virus-1: the EXPEDITION-2 Study.

artículo científico publicado en 2018

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials

Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials

artículo científico publicado en 2016

Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection

artículo científico publicado en 2017

Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a

artículo científico publicado en 2014

Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study

artículo científico publicado en 2017

Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial.

artículo científico publicado en 2015

Efficacy and safety of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C in persons with sickle cell disease.

artículo científico

Efficacy and safety of peginterferon alfa-2a/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administration

artículo científico publicado en 2008

Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease

artículo científico publicado en 2016

Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy

scientific article published on 08 August 2019

Elevated liver enzymes following initiation of antiretroviral therapy

Epidemiology and natural history of hepatitis C virus infection in injection drug users: implications for treatment

artículo científico publicado en 2005

Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy

artículo científico publicado en 2004

Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study

artículo científico publicado en 2004

Epoetin alfa once weekly improves anemia in HIV/hepatitis C virus-coinfected patients treated with interferon/ribavirin: a randomized controlled trial

artículo científico publicado en 2005

Estimating the Year Each State in the United States Will Achieve the World Health Organization's Elimination Targets for Hepatitis C

artículo científico publicado en 2020

Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States

artículo científico publicado en 2007

Ethical and Practical Issues Associated with the Possibility of Using Controlled Human Infection Trials in Developing a Hepatitis C Virus Vaccine

artículo científico publicado en 2020

Evaluating Noninvasive Markers to Identify Advanced Fibrosis by Liver Biopsy in HBV/HIV Co-infected Adults

scientific article published on 19 August 2019

Expert Panel Review on Non-Alcoholic Fatty Liver Disease in Persons with HIV

artículo científico publicado en 2020

Exploring the possibility of an interferon-free treatment regimen for hepatitis C virus infection ⬇️

artículo científico publicado el 1 de marzo de 2011

Extrahepatic morbidity and mortality of chronic hepatitis C.

artículo científico

Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore

artículo científico publicado en 2020

Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population

artículo científico publicado en 2010

Factors that predict response of patients with hepatitis C virus infection to boceprevir

artículo científico publicado en 2012

Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial.

artículo científico publicado en 2013

Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype 1 HCV: SILEN-C1 trial.

artículo científico publicado en 2013

Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials

artículo científico publicado en 2016

Fatty Liver Disease in a Prospective North American Cohort of Adults with HIV and Hepatitis B Coinfection

scientific article published on 01 September 2020

Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs

artículo científico publicado en 2014

Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection

artículo científico

Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C-Viremic Donors to Hepatitis C-Negative Recipients: An Open-Label Nonrandomized Study

artículo científico publicado en 2020

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

artículo científico publicado en 2009

Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients

artículo científico publicado en 2011

Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct-acting antiviral treatment

artículo científico publicado en 2017

Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis

artículo científico

Global transcriptional effects of PEG-IFN-alpha and ribavirin on peripheral blood cells obtained from patients with chronic hepatitis C.

artículo científico publicado en 2006

HCV DAA Therapy in Persons with HIV-HCV Genotype 1 Coinfection Results in High Rate of Sustained Virologic Response and Heterogeneity in Normalization of Soluble Markers of Immune Activation

scientific article published on 15 May 2020

HCV therapy in HIV-infected patients

artículo científico

HCV-HIV co-infected patients: no longer a 'special' population?

artículo científico

HIV and hepatitis C virus co-infection

article

Hazardous drinking is associated with an elevated aspartate aminotransferase to platelet ratio index in an urban HIV-infected clinical cohort

scientific article published on 20 December 2008

Hepatic profile analyses of tipranavir in Phase II and III clinical trials

artículo científico publicado en 2009

Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus

artículo científico publicado en 2005

Hepatic steatosis associated with increased central body fat by dual-energy X-ray absorptiometry and uncontrolled HIV in HIV/hepatitis C co-infected persons

artículo científico publicado en 2010

Hepatitis C Elimination in People With HIV Is Contingent on Closing Gaps in the HIV Continuum

scientific article published on 30 September 2019

Hepatitis C Treatment Uptake among People who Inject Drugs in the Oral Direct-Acting Antiviral Era

artículo científico publicado en 2020

Hepatitis C Virus Infection in HIV-infected Patients

artículo científico publicado en 2001

Hepatitis C Virus Postexposure Prophylaxis in the Healthcare Worker: Why Direct-Acting Antivirals Don't Change a Thing.

artículo científico publicado en 2016

Hepatitis C Virus Treatment: Simplifying the Simple and Optimizing the Difficult

artículo científico publicado en 2020

Hepatitis C and progression of HIV disease

artículo científico publicado en 2002

Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India.

artículo científico publicado en 2018

Hepatitis C coinfection gains a foothold at the 8th CROI

Hepatitis C genotype 1 infection in HIV-Infected patients in the era of direct-acting antiviral therapy

scientific article published on 23 July 2012

Hepatitis C in the HIV-Infected Person

artículo científico publicado en 2003

Hepatitis C in the HIV-infected patient

artículo científico publicado en 2003

Hepatitis C treatment among racial and ethnic groups in the IDEAL trial ⬇️

artículo científico publicado el 25 de noviembre de 2010

Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype

artículo científico publicado en 2010

Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals

artículo científico publicado en 2013

Hepatitis C virus and HIV co-infection: a sleeping giant wakes.

artículo científico publicado en 1999

Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection

artículo científico publicado en 2004

Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus

artículo científico publicado en 2000

Hepatitis C virus infection in HIV-infected patients

artículo científico publicado en 2004

Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate

artículo científico publicado en 2010

Hepatitis C virus-human immunodeficiency virus coinfection

artículo científico publicado en 2012

Hepatitis C virus: a critical appraisal of new approaches to therapy

artículo científico publicado en 2012

Hepatitis C-positive donor liver transplantation for hepatitis C seronegative recipients

artículo científico publicado en 2019

Hepatocellular carcinoma in HIV-infected patients comes of age: The convergence of epidemiology and treatment effectiveness

artículo científico publicado en 2009

Hepatotoxicity associated with antiretroviral therapy containing HIV-1 protease inhibitors.

artículo científico publicado en 2003

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

artículo científico publicado en 2000

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections

artículo científico publicado en 2002

Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir

artículo científico publicado en 2004

High Hepatitis C cure rates among black and non-black HIV-infected adults in an urban center

artículo científico

Hip bone geometry in HIV/HCV-co-infected men and healthy controls

artículo científico publicado en 2011

ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.

artículo científico publicado en 2010

ITX 5061 quantitation in human plasma with reverse phase liquid chromatography and mass spectrometry detection

scientific article published on 06 September 2012

Immunologic Predictors of Liver Transplantation Outcomes in HIV-HCV Co-Infected Persons

artículo científico publicado en 2015

Impact of a digital medicine programme on hepatitis C treatment adherence and efficacy in adults at high risk for non-adherence

scientific article published on 30 April 2020

Incidence and Risk Factors for Steatosis Progression in Adults Coinfected With HIV and Hepatitis C Virus ⬇️

artículo científico publicado el 4 de diciembre de 2010

Increased mortality among persons with chronic hepatitis C with moderate or severe liver disease: a cohort study

artículo científico publicado en 2017

Individual and network factors associated with HCV treatment uptake among people who inject drugs

scientific article published on 02 March 2020

Infections during peginterferon/ribavirin therapy are associated with the magnitude of decline in absolute lymphocyte count: results of the IDEAL study

artículo científico publicado en 2014

Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patients ⬇️

artículo científico publicado el 21 de agosto de 2010

Integrated hepatitis B virus DNA maintains surface antigen production during antivirals

artículo científico publicado en 2022

Interaction Between Alcohol Consumption Patterns, Antiretroviral Therapy Type, and Liver Fibrosis in Persons Living with HIV.

artículo científico publicado en 2016

Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta-analysis of randomized trials.

artículo científico publicado en 2001

Interferon γ-induced protein 10 kinetics in treatment-naive versus treatment-experienced patients receiving interferon-free therapy for hepatitis C virus infection: implications for the innate immune response

artículo científico publicado en 2014

Interferon-containing and interferon-free HCV therapy for HIV-infected patients

artículo científico

Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.

artículo científico publicado en 2012

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

artículo científico publicado en 2010

Intrahepatic Viral Kinetics during Direct-Acting Antivirals for Hepatitis C in HIV Co-infection:The ACTG A5335S Substudy

scientific article published on 23 March 2020

Intrapatient viral diversity and treatment outcome in patients with genotype 3a hepatitis C virus infection on sofosbuvir-containing regimens

artículo científico publicado en 2017

Is there a point at which you would recommend discontinuing treatment due to liver toxicity, short of liver failure? What, for instance, would be the numbers to look for with liver enzyme tests? How high is too high? My doctor has said they are seei

artículo científico publicado en 2001

Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution

artículo científico publicado en 2009

Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies.

artículo científico publicado en 2016

Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

artículo científico publicado en 2015

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.

artículo científico publicado en 2015

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

artículo científico publicado en 2014

Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis

artículo científico publicado en 2015

Lessons from HIV therapy applied to viral hepatitis therapy: summary of a workshop

artículo científico publicado en 2010

Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic

artículo científico publicado en 2006

Liver enzyme values in injection drug users with chronic hepatitis C.

artículo científico publicado en 2005

MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates

artículo científico publicado en 2009

Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy

artículo científico publicado en 2016

Management of acute and chronic HCV infection in persons with HIV coinfection

artículo científico publicado en 2014

Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C.

artículo científico publicado en 2011

Management of chronic hepatitis C

scientific article published on 01 June 2002

Management of hepatic complications in HIV-infected persons

artículo científico publicado en 2008

Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals

artículo científico publicado en 2012

Management of the Patient With HIV/Hepatitis C Drug Interactions: A Guide for Nurses and Nurse Practitioners

scientific article published on 01 March 2020

Management of the hematologic complications of hepatitis C therapy

artículo científico publicado en 2005

Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C.

artículo científico publicado en 2006

Morbidity and Mortality Among Community-Based People Who Inject Drugs With a High Hepatitis C and Human Immunodeficiency Virus Burden in Chennai, India

artículo científico publicado en 2016

NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome

artículo científico publicado en 2017

Needlestick injuries among surgeons in training

artículo científico publicado en 2007

Needlestick transmission of hepatitis C.

artículo científico publicado en 2002

Network-based recruitment of people who inject drugs for hepatitis C testing and linkage to care

scientific article published on 11 February 2020

No Evidence of Reactivation of Hepatitis B Virus Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection.

artículo científico publicado en 2016

Nurse case management to improve the hepatitis C care continuum in HIV co-infection: Results of a randomized controlled trial

artículo científico publicado en 2019

Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease.

artículo científico publicado en 2018

Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial

artículo científico

Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon alfa

artículo científico publicado en 2003

Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review

artículo científico publicado en 2017

Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials

artículo científico publicado en 2013

Overlapping epidemics of alcohol and illicit drug use among HCV-infected persons who inject drugs ⬇️

artículo científico publicado en 2019

PERCEPTIONS OF NETWORK BASED RECRUITMENT FOR HEPATITIS C TESTING AND TREATMENT AMONG PERSONS WHO INJECT DRUGS: A QUALITATIVE EXPLORATION

artículo científico publicado en 2020

Patient's Perspectives of Experimental HCV-Positive to HCV-Negative Renal Transplantation: Report from a Single Site

scientific article published on 16 October 2019

Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 study

artículo científico publicado en 2017

Peginterferon alfa-2a does not alter the pharmacokinetics of methadone in patients with chronic hepatitis C undergoing methadone maintenance therapy

artículo científico publicado en 2005

Peginterferon alfa-2a plus ribavirin for HIV-HCV genotype 1 coinfected patients: a randomized international trial

artículo científico publicado en 2012

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

artículo científico publicado en 2009

Peginterferon-alpha-2a (40kD) and ribavirin in patients with chronic hepatitis C: a phase II open-label study

artículo científico publicado en 2002

Perspectives on HIV/hepatitis C virus co-infection, illicit drug use and mental illness

artículo científico publicado en 2005

Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1.

artículo científico publicado en 2014

Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection.

artículo científico publicado en 2005

Plasma and intracellular ribavirin concentrations are not significantly altered by abacavir in hepatitis C virus-infected patients

artículo científico publicado en 2016

Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index

artículo científico publicado en 2005

Predictors of consent to pharmacogenomics testing in the IDEAL study.

artículo científico publicado en 2013

Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.–Canadian multicenter study

article

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

artículo científico publicado en 2001

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

artículo científico publicado en 2000

Primary Care Providers Knowledge, Attitude and Practices Related to Hepatitis C Screening and Treatment in the Oral Direct Acting Antiviral Agents Era.

artículo científico publicado en 2016

Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African-American elite controllers/suppressors

artículo científico publicado en 2011

Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons

artículo científico publicado en 2012

Public Masking: An Urgent Need to Revise Global Policies to Protect against Novel Coronavirus Disease (COVID-19)

scientific article published on 22 April 2020

Public health clinic-based hepatitis C testing and linkage to care in Baltimore.

artículo científico publicado en 2016

REPLACING INSULIN WITH ANTI-VIRALS: A CLINICAL VIGNETTE ON DIABETES AND HCV TREATMENT

artículo científico publicado en 2020

Racial differences in hepatitis C treatment eligibility ⬇️

artículo científico publicado el 1 de julio de 2011

Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334s

scientific article published on 12 December 2019

Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults

artículo científico publicado en 2007

Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin

artículo científico publicado en 2012

Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV

scientific article published on July 2012

Reply

artículo científico publicado en 2018

Reply to Ozaras et al.

artículo científico publicado en 2017

Response to Cytoplasmic rods and rings in ribavirin and Cytoplasmic rods and rings in mycophenolic acid treatment

artículo científico publicado en 2017

Response-guided telaprevir combination treatment for hepatitis C virus infection

artículo científico publicado en 2011

Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin

artículo científico publicado en 2014

Retrospective-Prospective Study of Safety and Efficacy of Sofosbuvir based Direct Acting Antivirals in HIV/HCV Coinfected Participants with Decompensated Liver Disease Pre or Post Liver Transplant

artículo científico publicado en 2020

Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection

artículo científico publicado en 2017

Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.

artículo científico publicado en 2016

Role of liver biopsy in management of chronic hepatitis C: a systematic review

artículo científico publicado en 2002

Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C.

artículo científico publicado en 2008

Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b study

scientific article published on 16 September 2013

Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study

artículo científico publicado en 2017

Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data

artículo científico publicado en 2015

Safety and efficacy of ombitasvir - 450/r and dasabuvir and ribavirin in HCV/HIV-1 co-infected patients receiving atazanavir or raltegravir ART regimens

artículo científico publicado en 2014

Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials

artículo científico publicado en 2015

Scientific rationale and study design of the individualized dosing efficacy vs flat dosing to assess optimal pegylated interferon therapy (IDEAL) trial: determining optimal dosing in patients with genotype 1 chronic hepatitis C.

artículo científico publicado en 2008

Scleritis and peripheral ulcerative keratitis with hepatitis C virus-related cryoglobulinemia

artículo científico publicado en 2007

Senior Center-Based Hepatitis C Screening in Baltimore

artículo científico publicado en 2016

Serum Fibrosis Markers for the Diagnosis of Liver Disease Among People With Chronic Hepatitis C in Chennai, India

artículo científico publicado en 2016

Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy

artículo científico publicado en 2010

Sharing the Cure: Building Primary Care and Public Health Infrastructure to Improve the Hepatitis C Care Continuum in Maryland

artículo científico publicado en 2020

Short-duration treatment for chronic hepatitis C virus with daclatasvir, asunaprevir, beclabuvir and sofosbuvir (FOURward study).

artículo científico publicado en 2016

Should a prisoner be placed on the organ transplant waiting list?

artículo científico publicado en 2008

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

artículo científico publicado en 2014

Single Hepatocyte Hepatitis B Virus Transcriptional Landscape in HIV Coinfection

artículo científico publicado en 2020

Single hepatocytes show persistence and transcriptional inactivity of hepatitis B

scientific article published on 02 October 2020

Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes

scientific article published on 12 January 2015

Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis

artículo científico publicado en 2016

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

artículo científico publicado en 2015

Sofosbuvir and Velpatasvir for Patients with HCV Infection

artículo científico publicado en 2016

Sofosbuvir and Velpatasvir for the Treatment of HCV in Patients Coinfected with HIV-1: an Open-Label, Phase 3 Study

artículo científico publicado en 2017

Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus

artículo científico publicado en 2016

Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection

artículo científico publicado en 2014

Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options

artículo científico publicado en 2013

Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial

artículo científico publicado en 2013

Sofosbuvir plus pegylated interferon and ribavirin in patients with genotype 1 hepatitis C virus in whom previous therapy with direct-acting antivirals has failed

artículo científico publicado en 2015

Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 Studies

artículo científico publicado en 2018

Sofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimen

artículo científico publicado en 2017

Sofosbuvir/Velpatasvir in Patients With Hepatitis C Virus Genotypes 1-6 and Compensated Cirrhosis or Advanced Fibrosis.

artículo científico publicado en 2017

Specific targeted antiviral therapy for hepatitis C.

artículo científico publicado en 2007

Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study

article

Stability of liver fibrosis among HCV-infected injection drug users

artículo científico publicado en 2012

Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3.

artículo científico publicado en 2011

Successful Re-treatment of Hepatitis C Virus in Patients Coinfected With HIV Who Relapsed After 12 Weeks of Ledipasvir/Sofosbuvir

artículo científico publicado en 2016

Superiority of Interferon-Free Regimens for Chronic Hepatitis C: The Effect on Health-Related Quality of Life and Work Productivity

artículo científico publicado en 2017

Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C)

artículo científico publicado en 2010

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

artículo científico publicado en 2009

The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States: A National Registry Study

artículo científico publicado en 2018

The Economic Value of Improved Productivity from Treatment of Chronic Hepatitis C Virus Infection: A Retrospective Analysis of Earnings, Work Loss, and Health Insurance Data

scientific article published on 14 September 2020

The HCV care continuum does not end with cure: A call to arms for the prevention of reinfection

artículo científico publicado en 2016

The HIV-coinfected patient: managing viral hepatitis

artículo científico publicado en 2007

The Proof Is in the Patient: Hepatitis C Virus Microelimination in the Swiss Human Immunodeficiency Virus Cohort Study

article

The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection

artículo científico publicado en 2012

The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons

artículo científico publicado en 2003

The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults

artículo científico publicado en 1998

The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection

artículo científico publicado en 2005

The emergence of NS5B resistance associated substitution S282T after sofosbuvir-based treatment.

artículo científico publicado en 2017

The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C.

artículo científico publicado en 2004

The new paradigm of hepatitis C therapy: integration of oral therapies into best practices

artículo científico publicado en 2013

The pharmacokinetics of peginterferon alfa-2a and ribavirin in African American, Hispanic and Caucasian patients with chronic hepatitis C.

artículo científico publicado en 2012

Therapeutic issues in HIV/HCV-coinfected patients

artículo científico publicado en 2007

Therapy insight: Management of hepatitis C in patients coinfected with HIV.

artículo científico publicado en 2005

Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin.

artículo científico publicado en 2016

Treatment algorithm for the management of hepatitis C in HIV-coinfected persons

artículo científico publicado en 2005

Treatment of chronic hepatitis B in HIV-infected persons: thinking outside the black box.

artículo científico publicado en 2005

Treatment of chronic hepatitis C: a systematic review

artículo científico publicado en 2002

Treatment of hepatitis C in HIV-infected persons: a work in progress

scientific article published on 08 November 2007

Understanding and addressing hepatitis C reinfection in the oral direct acting antiviral era.

artículo científico publicado en 2018

Unreported alcohol use was common but did not impact hepatitis C cure in HIV-infected persons who use drugs

scientific article published on 07 January 2020

Utilization of Hepatitis C RNA-positive Donor Liver for Transplant to Hepatitis C RNA-Negative Recipient.

artículo científico publicado en 2017

VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infection

artículo científico publicado en 2014

Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3

artículo científico publicado en 2011

Viral hepatitis and HIV coinfection

artículo científico publicado en 2007

Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir

artículo científico publicado en 2015

Virological response rates for telaprevir-based hepatitis C triple therapy in patients with and without HIV coinfection

artículo científico publicado en 2013

Vitamin D deficiency and its relation to bone mineral density and liver fibrosis in HIV-HCV coinfection

scientific article published on 07 August 2012

Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons

artículo científico publicado en 2006

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda